» Articles » PMID: 21712410

HIF Induces Human Embryonic Stem Cell Markers in Cancer Cells

Abstract

Low oxygen levels have been shown to promote self-renewal in many stem cells. In tumors, hypoxia is associated with aggressive disease course and poor clinical outcomes. Furthermore, many aggressive tumors have been shown to display gene expression signatures characteristic of human embryonic stem cells (hESC). We now tested whether hypoxia might be responsible for the hESC signature observed in aggressive tumors. We show that hypoxia, through hypoxia-inducible factor (HIF), can induce an hESC-like transcriptional program, including the induced pluripotent stem cell (iPSC) inducers, OCT4, NANOG, SOX2, KLF4, cMYC, and microRNA-302 in 11 cancer cell lines (from prostate, brain, kidney, cervix, lung, colon, liver, and breast tumors). Furthermore, nondegradable forms of HIFα, combined with the traditional iPSC inducers, are highly efficient in generating A549 iPSC-like colonies that have high tumorigenic capacity. To test potential correlation between iPSC inducers and HIF expression in primary tumors, we analyzed primary prostate tumors and found a significant correlation between NANOG-, OCT4-, and HIF1α-positive regions. Furthermore, NANOG and OCT4 expressions positively correlated with increased prostate tumor Gleason score. In primary glioma-derived CD133 negative cells, hypoxia was able to induce neurospheres and hESC markers. Together, these findings suggest that HIF targets may act as key inducers of a dynamic state of stemness in pathologic conditions.

Citing Articles

Hypoxia-inducible factor in cancer: from pathway regulation to therapeutic opportunity.

Ortmann B BMJ Oncol. 2025; 3(1):e000154.

PMID: 39886164 PMC: 11203102. DOI: 10.1136/bmjonc-2023-000154.


Genes and proteins expression profile of 2D vs 3D cancer models: a comparative analysis for better tumor insights.

Bhuker S, Sinha A, Arora A, Tuli H, Datta S, Saini A Cytotechnology. 2025; 77(2):51.

PMID: 39867829 PMC: 11759753. DOI: 10.1007/s10616-025-00714-w.


Can the reprogrammed cancer cells serve as an alternative source of (induced) cancer stem cells?.

Stelcer E, Blatkiewicz M, Jopek K, Suchorska W, Rucinski M Rep Pract Oncol Radiother. 2025; 29(5):651-656.

PMID: 39759558 PMC: 11698551. DOI: 10.5603/rpor.102821.


Role of Autophagy and AMPK in Cancer Stem Cells: Therapeutic Opportunities and Obstacles in Cancer.

Kovale L, Singh M, Kim J, Ha J Int J Mol Sci. 2024; 25(16).

PMID: 39201332 PMC: 11354724. DOI: 10.3390/ijms25168647.


Investigating Expression Dynamics of miR-21 and miR-10b in Glioblastoma Cells In Vitro: Insights into Responses to Hypoxia and Secretion Mechanisms.

Charbit H, Lavon I Int J Mol Sci. 2024; 25(14).

PMID: 39063226 PMC: 11277016. DOI: 10.3390/ijms25147984.


References
1.
Viswanathan S, Powers J, Einhorn W, Hoshida Y, Ng T, Toffanin S . Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet. 2009; 41(7):843-8. PMC: 2757943. DOI: 10.1038/ng.392. View

2.
Keith B, Simon M . Hypoxia-inducible factors, stem cells, and cancer. Cell. 2007; 129(3):465-72. PMC: 3150586. DOI: 10.1016/j.cell.2007.04.019. View

3.
Hu T, Liu S, Breiter D, Wang F, Tang Y, Sun S . Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis. Cancer Res. 2008; 68(16):6533-40. DOI: 10.1158/0008-5472.CAN-07-6642. View

4.
Yoshida Y, Takahashi K, Okita K, Ichisaka T, Yamanaka S . Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell. 2009; 5(3):237-41. DOI: 10.1016/j.stem.2009.08.001. View

5.
Ho A, Huang X, Cao H, Christman-Skieller C, Bennewith K, Le Q . Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer. Transl Oncol. 2010; 3(2):109-13. PMC: 2847318. DOI: 10.1593/tlo.09256. View